Details for Patent: 12,156,866
✉ Email this page to a colleague
Which drugs does patent 12,156,866 protect, and when does it expire?
Patent 12,156,866 protects VELSIPITY and is included in one NDA.
This patent has fourteen patent family members in twelve countries.
Summary for Patent: 12,156,866
| Title: | Methods of treating conditions related to the S1P1 receptor |
| Abstract: | Provided are methods of treatment of a sphingosine 1-phosphate subtype 1 (S1P1) receptor-associated disorder comprising prescribing and/or administering to an individual in need thereof a standard dose of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl) benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid (Compound 1), or a pharmaceutically acceptable salt, hydrate, or solvate thereof. |
| Inventor(s): | Ronald J. Christopher, Abu J. M. Sadeque |
| Assignee: | Arena Pharmaceuticals Inc |
| Application Number: | US15/734,920 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 12,156,866
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | VELSIPITY | etrasimod arginine | TABLET;ORAL | 216956-001 | Oct 12, 2023 | RX | Yes | Yes | 12,156,866 | ⤷ Start Trial | A METHOD FOR TREATING ULCERATIVE COLITIS BY ADMINISTERING A THERAPEUTICALLY EFFECTIVE AMOUNT OF ESTRASIMOD ARGININE AS CLAIMED | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,156,866
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019280822 | ⤷ Start Trial | |||
| Brazil | 112020024762 | ⤷ Start Trial | |||
| Canada | 3102136 | ⤷ Start Trial | |||
| China | 112601516 | ⤷ Start Trial | |||
| European Patent Office | 3801459 | ⤷ Start Trial | |||
| Spain | 2987794 | ⤷ Start Trial | |||
| Israel | 279180 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
